| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |